SHIRVAN MITCHELL enters SILEXION THERAPEUTICS CORP with 132.47K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/15/2024ACC: 0001213900-24-069880
Officer· CSO and CDO
Since Feb 2026
132.47K
Baseline shares
100% direct
132.47K
Direct ownership
1 position
64.52K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned132.47K
Total
132.47K direct132.47K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 132.47K | Direct |
| Total | 132.47K | 132.47K direct |
Derivative Holdings1
Stock Option (right to buy ordinary shares)
DirectUnderlying security
Ordinary Shares
Underlying shares
64.52K
Shares owned
N/A
Exercise price
6.72
Expiration
—
Exercise window
—
Total
Underlying
64.52K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy ordinary shares) Direct | Ordinary Shares | 6.72 | — | — | 64.52K | N/A |
| Total | 64.52K | 0.00 | ||||